HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Advice from CMDh
  • >Product-related advice
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
    • COVID-19
    • BREXIT
    • Nitrosamine impurities
    • Procedural Guidance
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
      • Procedural advice
      • Product-related advice
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
    • Falsified Medicines
    • Questions & Answers
    • Contact Points
    • Recently Published history
  • MRI Product Index
  • Pharmacovigilance
  • Availability of Medicines
  • Publications and reports
  • National Contacts

 

Product-related advice

  • CMDh letter to MAHs of tenofovir disoproxil-containing medicinal products (February 2023, correction: June 2023)
  • Q&As on the implementation of the outcome of the Art. 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group (December 2021) [Tracked]
  • Harmonised warning for ferrous sulfate-containing medicinal products on dysphagia and related bronchostenosis due to risk of aspiration (May 2018) [Tracked]
  • Concomitant use of benzodiazepines/benzodiazepine like products and opioids (February 2018)
  • CMDh letter for MAHs for medicinal products containing active ingredients in the form of Mesilates, Isetionates, Tosilates or Besilates (February 2008)

Deletion of interaction between broad spectrum antibiotics and combined oral contraceptives (COC)

 

  • Public Assessment Report (March 2015) corrected in March 2016 [Tracked]
  • List of ATC codes for which the change applies (January 2016)

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/human-medicines/cmdh/advice-from-cmdh/product-related-advice.html